ZEPZELCA
As listed in the register: ZEPZELCA 4 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
4 mg · polvo para concentrado para solución para perfusión
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Lurbinectedina
- Made by
- Pharma Mar S.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Pharma Mar S.A. |
|---|---|
| Active substance | Lurbinectedina |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 4 mg |
| Form | polvo para concentrado para solución para perfusión |
| Classification | L01XX69 · Cancer treatments and immune-system medicines |
| Route | vía intravenosa |
| Marketed | No — authorised but not currently marketed, according to the register |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | ZEPZELCA 4 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION |
| Nº Registro | 1262032002 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- polvo para concentrado para solución para perfusión2 products
- 2 mg
- 4 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.